Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation

Thromb Haemost. 2008 Mar;99(3):640-2. doi: 10.1160/TH07-09-0570.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Case-Control Studies
  • Contraceptives, Oral, Combined / adverse effects*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Intracranial Thrombosis / chemically induced
  • Intracranial Thrombosis / genetics
  • Italy
  • Janus Kinase 2 / genetics*
  • Mesenteric Vascular Occlusion / chemically induced
  • Mesenteric Vascular Occlusion / genetics
  • Mesenteric Veins
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / genetics
  • Portal Vein
  • Risk Factors
  • Thrombophilia / complications
  • Thrombophilia / genetics
  • Venous Thromboembolism / chemically induced
  • Venous Thromboembolism / genetics
  • Venous Thrombosis / chemically induced
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / genetics
  • Venous Thrombosis / mortality

Substances

  • Contraceptives, Oral, Combined
  • JAK2 protein, human
  • Janus Kinase 2